Artwork

Content provided by Texas Tech Health El Paso IA Webmaster, Dr. Richard Lange, and Elizabeth Tracey. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Texas Tech Health El Paso IA Webmaster, Dr. Richard Lange, and Elizabeth Tracey or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Oral GLP-1 agonist, Satiety Pathways, and Stem Cell tx for T1D

12:57
 
Share
 

Manage episode 491179233 series 1110501
Content provided by Texas Tech Health El Paso IA Webmaster, Dr. Richard Lange, and Elizabeth Tracey. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Texas Tech Health El Paso IA Webmaster, Dr. Richard Lange, and Elizabeth Tracey or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Program notes:

0:40 Stem cells for type 1 diabetes

1:40 None had hypoglycemia afterwards

2:40 Autologous stem cells?

3:20 Oral GLP-1 agonist

4:20 Primary endpoint HbA1c reduction

5:20 Weight loss modest

6:20 Injectable GLP-1 plus an amylin analogue

7:20 Both those with diabetes and those without

8:20 No increased safety events

8:40 Mental health hospitalizations in adolescents

9:40 KID database

10:40 Females accounting for increase

11:40 67% of hospitalizations

12:57 End

  continue reading

28 episodes

Artwork
iconShare
 
Manage episode 491179233 series 1110501
Content provided by Texas Tech Health El Paso IA Webmaster, Dr. Richard Lange, and Elizabeth Tracey. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Texas Tech Health El Paso IA Webmaster, Dr. Richard Lange, and Elizabeth Tracey or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Program notes:

0:40 Stem cells for type 1 diabetes

1:40 None had hypoglycemia afterwards

2:40 Autologous stem cells?

3:20 Oral GLP-1 agonist

4:20 Primary endpoint HbA1c reduction

5:20 Weight loss modest

6:20 Injectable GLP-1 plus an amylin analogue

7:20 Both those with diabetes and those without

8:20 No increased safety events

8:40 Mental health hospitalizations in adolescents

9:40 KID database

10:40 Females accounting for increase

11:40 67% of hospitalizations

12:57 End

  continue reading

28 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play